We can't even get an update from the TGA on Viraleze since 1 June 2024 has come and gone and a final decision was expected ..... maybe they wanted more information again ? What a drama over a simple nasal spray - and I use the term 'simple' because it will only be approved by the TGA as a cold and flu nasal spray with no COVID-19 references allowed in Australia so it is amazing it has taken this long ?
Agree @chrisnj .... until a reasonable sized pharma group show any interest in the DEP® tech by licensing either DEP® Cabazitaxel or DEP® Irinotecan with a substantial $ upfront attached, IMO we wont see any appreciation of the current all time record low share price .... perhaps an announcement that JF's consultancy role has finally ceased altogether might give us a boost ? lol
SPL Price at posting:
11.0¢ Sentiment: None Disclosure: Held
